Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference newsletter


  Cervical Cancer

  Free Subscription


07.09.2020

1 Adv Prev Med
1 Ann Surg Oncol
1 Anticancer Res
2 Arch Gynecol Obstet
1 Arch Med Sci
1 Asia Pac J Clin Oncol
1 Biochem Biophys Res Commun
1 Biochim Biophys Acta Mol Cell Res
3 BJOG
2 BMC Cancer
3 Cancer Cell Int
1 Cancer Genomics Proteomics
1 Cancer Res Treat
1 Cell Biochem Funct
2 Cleve Clin J Med
2 Clin Case Rep
1 Comb Chem High Throughput Screen
1 Cureus
1 Diagnostics (Basel)
1 Eur J Surg Oncol
1 Eur Radiol
1 Exp Biol Med (Maywood)
1 Gynecol Oncol
1 In Vivo
1 Int Immunopharmacol
2 Int J Environ Res Public Health
1 Int J Gynecol Cancer
1 J Biophotonics
1 J BUON
2 J Int Med Res
1 J Med Screen
1 J Recept Signal Transduct Res
2 Lancet Glob Health
1 Life Sci
1 MDM Policy Pract
1 Med Dosim
1 Onco Targets Ther
1 Pan Afr Med J
1 PLoS One
1 Rev Prat
1 Virchows Arch
1 World J Surg Oncol
1 Zhong Nan Da Xue Xue Bao Yi Xue Ban


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Adv Prev Med

  1. DESSALEGN MEKONNEN B
    Cervical Cancer Screening Uptake and Associated Factors among HIV-Positive Women in Ethiopia: A Systematic Review and Meta-Analysis.
    Adv Prev Med. 2020;2020:7071925.
    PubMed         Abstract available


    Ann Surg Oncol

  2. ZANAGNOLO V, Baroni C, Achilarre MT, Aloisi A, et al
    Oncologic Outcomes of Robotic Radical Hysterectomy (RRH) for Patients with Early-Stage Cervical Cancer: Experience at a Referral Cancer Center.
    Ann Surg Oncol. 2020 Aug 28. pii: 10.1245/s10434-020-09016.
    PubMed         Abstract available


    Anticancer Res

  3. GADDUCCI A, Cosio S
    Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer: Review of the Literature and Perspectives of Clinical Research.
    Anticancer Res. 2020;40:4819-4828.
    PubMed         Abstract available


    Arch Gynecol Obstet

  4. BRAUTIGAM K, Ehret C, Schillinger V, Baum S, et al
    Analysis of HPV genotype-specific concordance between EUROArray HPV and HPV 3.5 LCD-Array Kit in cervical samples of 163 patients.
    Arch Gynecol Obstet. 2020;301:745-751.
    PubMed         Abstract available

  5. HU D, Sun S, Wang Y
    MicroRNA-455-5p exerts inhibitory effect in cervical carcinoma through targeting S1PR1 and blocking mTOR pathway.
    Arch Gynecol Obstet. 2020;301:1307-1315.
    PubMed         Abstract available


    Arch Med Sci

  6. LIU H, Liu J, Zhao G
    Long non-coding RNA HOTAIR regulates proliferation, migration and invasion of human cervical cancer cells by modulating expression of MAPK1.
    Arch Med Sci. 2019;16:1158-1165.
    PubMed         Abstract available


    Asia Pac J Clin Oncol

  7. WEN N, Bian L, Gon J, Meng Y, et al
    RPRD1B is a potentially molecular target for diagnosis and prevention of human papillomavirus E6/E7 infection-induced cervical cancer: A case-control study.
    Asia Pac J Clin Oncol. 2020 Aug 31. doi: 10.1111/ajco.13439.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  8. WANG T, Liu Q, Duan L
    MBNL1 regulates resistance of HeLa cells to cisplatin via Nrf2.
    Biochem Biophys Res Commun. 2020;522:763-769.
    PubMed         Abstract available


    Biochim Biophys Acta Mol Cell Res

  9. DAS S, Chandrasekaran AP, Jo KS, Ko NR, et al
    stabilizes Cdc25A and protects cervical cancer cells from DNA damage response.
    Biochim Biophys Acta Mol Cell Res. 2020 Aug 26:118835.
    PubMed         Abstract available


    BJOG

  10. LOOPIK DL, Melchers WJ, Vedder JE, van den Brule AJ, et al
    Authors' reply re: Reflex cytology for triage of high-risk human-papillomavirus-positive self-sampled material in cervical cancer screening: a prospective cohort study.
    BJOG. 2020 Aug 31. doi: 10.1111/1471-0528.16442.
    PubMed        

  11. TIDY JA, Lyon R, Ellis K, Macdonald M, et al
    The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study.
    BJOG. 2020;127:1260-1267.
    PubMed         Abstract available

  12. SONG F, Yan P, Wu R
    Re: Reflex cytology for triage of high-risk human papillomavirus positive self-sampled material in cervical cancer screening: a prospective cohort study.
    BJOG. 2020 Sep 1. doi: 10.1111/1471-0528.16443.
    PubMed        


    BMC Cancer

  13. XIE G, Wang R, Shang L, Qi C, et al
    Calculating the overall survival probability in patients with cervical cancer: a nomogram and decision curve analysis-based study.
    BMC Cancer. 2020;20:833.
    PubMed         Abstract available

  14. ABDALLA E, Troy R, Fall S, Elhussin I, et al
    Racial differences in 5-year relative survival rates of cervical cancer by stage at diagnosis, between African American (black) and white women, living in the state of Alabama, USA.
    BMC Cancer. 2020;20:830.
    PubMed         Abstract available


    Cancer Cell Int

  15. ZOU D, Dong L, Li C, Yin Z, et al
    Correction to: The m(6)A eraser FTO facilitates proliferation and migration of human cervical cancer cells.
    Cancer Cell Int. 2020;20:423.
    PubMed         Abstract available

  16. DONG B, Chen L, Lin W, Su Y, et al
    Cost-effectiveness and accuracy of cervical cancer screening with a high-risk HPV genotyping assay vs a nongenotyping assay in China: an observational cohort study.
    Cancer Cell Int. 2020;20:421.
    PubMed         Abstract available

  17. LIU J, Liu X, Li R
    LncRNA SNHG6 enhances the radioresistance and promotes the growth of cervical cancer cells by sponging miR-485-3p.
    Cancer Cell Int. 2020;20:424.
    PubMed         Abstract available


    Cancer Genomics Proteomics

  18. MORENO-ACOSTA P, Molano M, Morales N, Acosta J, et al
    hTERT Protein Expression in Cytoplasm and Nucleus and its Association With HPV Infection in Patients With Cervical Cancer.
    Cancer Genomics Proteomics. 2020;17:615-625.
    PubMed         Abstract available


    Cancer Res Treat

  19. LIN W, Chen B, Wu B, Yuan S, et al
    Cervical Cancer Screening Rate and Willingness among Female Migrants in Shenzhen, China: Three-Year Changes in Citywide Surveys.
    Cancer Res Treat. 2020 Sep 1. pii: crt.2020.219. doi: 10.4143/crt.2020.
    PubMed         Abstract available


    Cell Biochem Funct

  20. WEI J, Wang L, Sun Y, Bao Y, et al
    LINC00662 contributes to the progression and the radioresistance of cervical cancer by regulating miR-497-5p and CDC25A.
    Cell Biochem Funct. 2020 Sep 1. doi: 10.1002/cbf.3580.
    PubMed         Abstract available


    Cleve Clin J Med

  21. BATUR P
    The HPV vaccine: Understanding and addressing barriers to vaccination.
    Cleve Clin J Med. 2020;87:545-548.
    PubMed        

  22. VEGUNTA S, Long ME
    Should women with HPV-related noncervical cancers be considered at high risk for cervical cancer?
    Cleve Clin J Med. 2020;87:541-544.
    PubMed        


    Clin Case Rep

  23. ALELE D, Dahn B, Camanor S, Ikpi E, et al
    Novel use of fine needle aspiration (FNA) biopsy to diagnose cervical cancer in a low-resource setting: A case series Morovia, Liberia.
    Clin Case Rep. 2020;8:1413-1418.
    PubMed         Abstract available

  24. OTA Y, Suzuki Y, Matsunaga T, Ninomiya R, et al
    New combined surgery for cervical cancer complicated by pelvic organ prolapse using autologous fascia lata: A case report.
    Clin Case Rep. 2020;8:1382-1386.
    PubMed         Abstract available


    Comb Chem High Throughput Screen

  25. TAVAKOLI F, Khatami SS, Momeni F, Azadbakht J, et al
    Cervical Cancer Diagnosis: Insights into Biochemical Biomarkers and Imaging techniques.
    Comb Chem High Throughput Screen. 2020 Aug 31. pii: CCHTS-EPUB-109594.
    PubMed         Abstract available


    Cureus

  26. DAWSON JQ, Davies JM, Ingledew PA
    Quality of Online Information Regarding Cervical Cancer.
    Cureus. 2020;12:e9511.
    PubMed         Abstract available


    Diagnostics (Basel)

  27. PENG NJ, Hu C, Chiu YL, Yu CC, et al
    Detection of Recurrent Cervical Cancer and Prediction of Its Patient Survival with Serum Squamous-Cell Carcinoma-Antigen and 2-[(18)F] Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography/Computed Tomography.
    Diagnostics (Basel). 2020;10.
    PubMed         Abstract available


    Eur J Surg Oncol

  28. MATSUO K, Nusbaum DJ, Klar M, Matsuzaki S, et al
    Utility of the 3-tier grouping system for survival discriminatory ability in stage IIA cervical cancer.
    Eur J Surg Oncol. 2020 Jun 15. pii: S0748-7983(20)30538.
    PubMed         Abstract available


    Eur Radiol

  29. PERUCHO JAU, Wang M, Tse KY, Ip PPC, et al
    Association between MRI histogram features and treatment response in locally advanced cervical cancer treated by chemoradiotherapy.
    Eur Radiol. 2020 Sep 3. pii: 10.1007/s00330-020-07217.
    PubMed         Abstract available


    Exp Biol Med (Maywood)

  30. YU X, Xia J, Cao Y, Tang L, et al
    SNHG1 represses the anti-cancer roles of baicalein in cervical cancer through regulating miR-3127-5p/FZD4/Wnt/beta-catenin signaling.
    Exp Biol Med (Maywood). 2020 Sep 3:1535370220955139.
    PubMed         Abstract available


    Gynecol Oncol

  31. DE JAEGHERE EA, Laloo F, Lippens L, Van Bockstal M, et al
    Splenic (18)F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer.
    Gynecol Oncol. 2020 Aug 25. pii: S0090-8258(20)33757.
    PubMed         Abstract available


    In Vivo

  32. CHUEH FS, Lien JC, Chou YC, Huang WW, et al
    Demethoxycurcumin Inhibits In Vivo Growth of Xenograft Tumors of Human Cervical Cancer Cells.
    In Vivo. 2020;34:2469-2474.
    PubMed         Abstract available


    Int Immunopharmacol

  33. NATH N, Mishra P, Panda AK, Mishra R, et al
    Polymorphisms and haplotypes of TLR4, TLR9 and CYP1A1 genes possibly interfere with high-risk human papillomavirus infection and cervical cancer susceptibility in Jharkhand, India.
    Int Immunopharmacol. 2020;88:106925.
    PubMed         Abstract available


    Int J Environ Res Public Health

  34. KIM J, Lee D, Son KB, Bae S, et al
    The Burden of Cervical Cancer in Korea: A Population-Based Study.
    Int J Environ Res Public Health. 2020;17.
    PubMed         Abstract available

  35. WONG EL, Cheung AW, Wong AY, Chan PK, et al
    Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
    Int J Environ Res Public Health. 2020;17.
    PubMed         Abstract available


    Int J Gynecol Cancer

  36. BONA AF, Ferreira KR, Carvalho RBM, Thuler LCS, et al
    Incidence, prevalence, and factors associated with lymphedema after treatment for cervical cancer: a systematic review.
    Int J Gynecol Cancer. 2020 Aug 30. pii: ijgc-2020-001682.
    PubMed         Abstract available


    J Biophotonics

  37. SHI W, Wang Y, Hou L, Ma C, et al
    Detection of Living Cervical Cancer Cells by Transient Terahertz Spectroscopy.
    J Biophotonics. 2020 Aug 30. doi: 10.1002/jbio.202000237.
    PubMed         Abstract available


    J BUON

  38. LIU T, Zhao X, Song D, Liu Y, et al
    Anticancer activity of Eremanthin against the human cervical cancer cells is due to G2/M phase cell cycle arrest, ROS-mediated necrosis-like cell death and inhibition of PI3K/AKT signalling pathway.
    J BUON. 2020;25:1547-1553.
    PubMed         Abstract available


    J Int Med Res

  39. YANG SL, Chen L, He Y, Zhao H, et al
    Effect of neoadjuvant chemotherapy followed by surgery for FIGO stage I-II cervical cancer: a meta-analysis.
    J Int Med Res. 2020;48:300060520945507.
    PubMed         Abstract available

  40. JI J, Zhu H, Zhao JZ, Yang YQ, et al
    Negative emotions and their management in Chinese convalescent cervical cancer patients: a qualitative study.
    J Int Med Res. 2020;48:300060520948758.
    PubMed         Abstract available


    J Med Screen

  41. SONG F, Du H, Wang C, Huang X, et al
    The effectiveness of human papillomavirus load, reflected by cycle threshold values, for the triage of HPV-positive self-samples in cervical cancer screening.
    J Med Screen. 2020 Sep 1:969141320943634. doi: 10.1177/0969141320943634.
    PubMed         Abstract available


    J Recept Signal Transduct Res

  42. ZUO X, Li L, Sun L
    Plantamajoside inhibits hypoxia-induced migration and invasion of human cervical cancer cells through the NF-kappaB and PI3K/akt pathways.
    J Recept Signal Transduct Res. 2020.
    PubMed         Abstract available


    Lancet Glob Health

  43. SABOUR S
    Assessing the diagnostic value of Xpert HPV.
    Lancet Glob Health. 2020;8:e997.
    PubMed        

  44. KUHN L, Saidu R, Denny L
    Assessing the diagnostic value of Xpert HPV - Authors' reply.
    Lancet Glob Health. 2020;8:e998.
    PubMed        


    Life Sci

  45. BALASUBRAMANIAM SD, Wong KK, Oon CE, Balakrishnan V, et al
    Comparative transcriptomic profiling in HPV-associated cervical carcinogenesis: Implication of MHC class II and immunoglobulin heavy chain genes.
    Life Sci. 2020;256:118026.
    PubMed         Abstract available


    MDM Policy Pract

  46. HOLT HK, Kulasingam S, Sanstead EC, Alarid-Escudero F, et al
    Discussing Cervical Cancer Screening Options: Outcomes to Guide Conversations Between Patients and Providers.
    MDM Policy Pract. 2020;5:2381468320952409.
    PubMed         Abstract available


    Med Dosim

  47. SAVANOVIC M, Strbac B
    Assessment of robustness of institutional applied clinical target volume (CTV) to planning target volume (PTV) margin in cervical cancer using biological models.
    Med Dosim. 2020 Aug 29. pii: S0958-3947(20)30122.
    PubMed         Abstract available


    Onco Targets Ther

  48. GUO L, Hua K
    Cervical Cancer: Emerging Immune Landscape and Treatment.
    Onco Targets Ther. 2020;13:8037-8047.
    PubMed         Abstract available


    Pan Afr Med J

  49. OKEDO-ALEX IN, Uneke CJ, Uro-Chukwu HC, Akamike IC, et al
    "It is what I tell her that she will do": a mixed methods study of married men's knowledge and attitude towards supporting their wives' cervical cancer screening in rural South-East Nigeria.
    Pan Afr Med J. 2020;36:156.
    PubMed         Abstract available


    PLoS One

  50. CHAUHAN AS, Prinja S, Srinivasan R, Rai B, et al
    Cost effectiveness of strategies for cervical cancer prevention in India.
    PLoS One. 2020;15:e0238291.
    PubMed         Abstract available


    Rev Prat

  51. BALDAUF JJ, Lecointre L, Akladios CY, Faller E, et al
    [Cervical cancer screening must go on!]
    Rev Prat. 2020;70:109-110.
    PubMed        


    Virchows Arch

  52. STOLNICU S, McCluggage WG
    The evolving spectrum of endocervical adenocarcinoma in situ (AIS).
    Virchows Arch. 2020;476:485-486.
    PubMed        


    World J Surg Oncol

  53. LEWANDOWSKA A, Szubert S, Koper K, Koper A, et al
    Analysis of long-term outcomes in 44 patients following pelvic exenteration due to cervical cancer.
    World J Surg Oncol. 2020;18:234.
    PubMed         Abstract available


    Zhong Nan Da Xue Xue Bao Yi Xue Ban

  54. JIANG Y, Wang Q, Xu Q, Zhang S, et al
    Predictive value of S100A9 for lymph node metastasis in cervical cancer.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020;45:701-708.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: